2016
DOI: 10.1002/jso.24512
|View full text |Cite
|
Sign up to set email alerts
|

Nomogram for predicting central node metastasis in papillary thyroid carcinoma

Abstract: We recommend the use of our nomogram to enable clinicians and patients to easily personalize and quantify the probability of CLNM during the both pre- and postoperative period. Clinicians may consider the prophylactic CND and meticulous postoperative evaluation in PTC patients with a high nomogram score. J. Surg. Oncol. 2017;115:266-272. © 2016 Wiley Periodicals, Inc.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

6
60
1

Year Published

2017
2017
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 46 publications
(67 citation statements)
references
References 48 publications
6
60
1
Order By: Relevance
“…Moreover, in the previous studies for constructing nomograms, the size of the validation cohort was approximately one-third to half of training cohort. [10][11][12][13][14][15] Therefore, we randomly assigned 70% of the enrolled eligible patients to the training cohort (n = 692) and 30% of the enrolled eligible patients to the validation cohort (n = 296). The training cohort was used to establish the predictive model and to develop the nomogram.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Moreover, in the previous studies for constructing nomograms, the size of the validation cohort was approximately one-third to half of training cohort. [10][11][12][13][14][15] Therefore, we randomly assigned 70% of the enrolled eligible patients to the training cohort (n = 692) and 30% of the enrolled eligible patients to the validation cohort (n = 296). The training cohort was used to establish the predictive model and to develop the nomogram.…”
Section: Discussionmentioning
confidence: 99%
“…To make the best use of our data for constructing the predictive model, we managed to make a higher ratio of training cohort, and we also kept a considerable number of patients for validation of our model. Moreover, in the previous studies for constructing nomograms, the size of the validation cohort was approximately one‐third to half of training cohort 10–15 . Therefore, we randomly assigned 70% of the enrolled eligible patients to the training cohort (n = 692) and 30% of the enrolled eligible patients to the validation cohort (n = 296).…”
Section: Methodsmentioning
confidence: 99%
“…Nomograms have been used in most cancer types in recent years [25][26][27][28][29][30][31][32] , including for ccRCC [33][34][35] . However, there has been a lack of overall evaluations of the developed nomograms, or the variables used for prediction have not been readily available.…”
Section: Discussionmentioning
confidence: 99%
“…Nomograms have been used in most cancer types in recent years [24][25][26][27][28][29][30][31] , including for ccRCC [32][33][34] .…”
Section: Discussionmentioning
confidence: 99%